Marshall Wace
ONCS

Marshall Wace’s OncoSec Medical Incorporated ONCS Stock Holding History

Marshall Wace’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-718
Closed -$102K – 3091
2020
Q4 		$102K Buy
+718
New +$76.6K ﹤0.01% 1800

Other funds holding ONCS

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

Marshall Wace's ONCS Position: Q1 2021 in Review

Marshall Wace sold out of OncoSec Medical Incorporated (ONCS) in Q1 2021, closing a stake of 718 shares — an estimated $102K sold.

Marshall Wace first reported a position in ONCS in Q4 2020 and held it in 1 quarter. The position peaked at $102K in Q4 2020. 34 funds tracked by Wall St. Rank hold ONCS as of Q1 2021.

  • Marshall Wace reported no remaining OncoSec Medical Incorporated position as of Q1 2021 after selling out during the quarter.
  • Marshall Wace sold 718 OncoSec Medical Incorporated shares in Q1 2021, an estimated $102K.
  • Marshall Wace first reported a position in OncoSec Medical Incorporated in Q4 2020 and held it in 1 quarter.
  • Marshall Wace's OncoSec Medical Incorporated position peaked at $102K in Q4 2020.
  • 34 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2021.

Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.